Thrivent Financial for Lutherans’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
49,830
+401
| +0.8% | +$3.27K | ﹤0.01% | 2221 |
|
|
2025
Q1 | $388K | Buy |
49,429
+7,696
| +18% | +$60.4K | ﹤0.01% | 2159 |
|
|
2024
Q4 | $621K | Sell |
41,733
-627
| -1% | -$9.33K | ﹤0.01% | 2164 |
|
|
2024
Q3 | $648K | Sell |
42,360
-2,943
| -6% | -$45K | ﹤0.01% | 2138 |
|
|
2024
Q2 | $690K | Sell |
45,303
-1,592
| -3% | -$24.2K | ﹤0.01% | 2067 |
|
|
2024
Q1 | $885K | Sell |
46,895
-1,131
| -2% | -$21.3K | ﹤0.01% | 1961 |
|
|
2023
Q4 | $917K | Sell |
48,026
-1,046
| -2% | -$20K | ﹤0.01% | 1893 |
|
|
2023
Q3 | $881K | Sell |
49,072
-1,281
| -3% | -$23K | ﹤0.01% | 1830 |
|
|
2023
Q2 | $1.02M | Sell |
50,353
-1,312
| -3% | -$26.7K | ﹤0.01% | 1787 |
|
|
2023
Q1 | $942K | Sell |
51,665
-1,811
| -3% | -$33K | ﹤0.01% | 1823 |
|
|
2022
Q4 | $1.11M | Sell |
53,476
-231
| -0.4% | -$4.78K | ﹤0.01% | 1661 |
|
|
2022
Q3 | $1.41M | Buy |
53,707
+7,908
| +17% | +$207K | ﹤0.01% | 1458 |
|
|
2022
Q2 | $1.16M | Buy |
+45,799
| New | +$1.16M | ﹤0.01% | 1611 |
|